FDA's working relationship with the European Medicines Agency may facilitate the creation of more competition in drug markets and provide another potential solution to rising prices.
Sen. Bill Cassidy, R-La., suggested that small molecule generics with no competition could be imported from Europe, if supply chain...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?